Whole sample (n=631) | P value | NGT (n=446) | P value | IFG (n=60) | P value | IGT (n=95) | P value | Type 2 diabetes (n=30) | P value | |
Triglyceride/HDL-C ratio | −0.411 | <0.0001 | −0.407 | <0.0001 | −0.292 | 0.01 | −0.109 | 0.14 | −0.314 | 0.09 |
LAP index | −0.469 | <0.0001 | −0.442 | <0.0001 | −0.488 | <0.0001 | −0.252 | 0.007 | −0.472 | 0.008 |
VAI | −0.392 | <0.0001 | −0.372 | <0.0001 | −0.316 | 0.007 | −0.129 | 0.10 | −0.327 | 0.07 |
TyG index | −0.385 | <0.0001 | −0.374 | <0.0001 | −0.268 | 0.01 | −0.028 | 0.39 | −0.332 | 0.07 |
HDL-C, high-density lipoprotein cholesterol; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; LAP, lipid accumulation product; NGT, normal glucose tolerance; TyG, triglycerides × fasting glucose; VAI, visceral adiposity index.